Acta Pharmaceutica Sinica B
|
2025, 15(11): 6087-6088
• Commentaries •
AT-17 redefines local anesthetics by targeting mitochondrial apoptosis
Full
Xiaoyuan Chen1,2,3,4,5,6,7,8
Affiliations
1 Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore;
2 Department of Chemical and Biomolecular Engineering, College of Design and Engineering, National University of Singapore, Singapore 117575, Singapore;
3 Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore 117575, Singapore;
4 Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, Singapore 117544, Singapore;
5 Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore;
6 Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore;
7 Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore 138667, Singapore;
8 Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), Singapore 138673, Singapore
doi: 10.1016/j.apsb.2025.10.013
Outline
Oral local anesthetics
/
Articaine
/
Mitochondria
/
Apoptosis
Xiaoyuan Chen.
AT-17 redefines local anesthetics by targeting mitochondrial apoptosis[J].
Acta Pharmaceutica Sinica B,
2025
, 15
(11)
: 6087
-6088
.
DOI: 10.1016/j.apsb.2025.10.013
Year 2025 volume 15 Issue 11
PDF
63
18
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.10.013